STOCK TITAN

Scynexis director granted 5,750 RSUs, options

A SCYNEXIS director received time-based RSU and option grants totaling 11,500 share-linked awards that vest over three years.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

SCYNEXIS INC (SCYX) reported that director Steven Keith Burke received new equity awards on September 18, 2026. He was granted 5,750 restricted stock units, each convertible into one share of common stock as they vest, and 5,750 stock options to buy common shares at an exercise price of $4.46 per share, expiring on September 18, 2036. One third of the RSUs will vest each year on the grant-date anniversary starting September 18, 2027, and the options vest one third on the first anniversary of the grant date, with the remaining two thirds vesting in equal monthly installments over the following 24 months, in each case contingent on his continued service. Following these awards he holds 5,750 common shares directly, plus 5,750 stock options, and no Rule 10b5-1 trading plan is reported.

Positive

  • None.

Negative

  • None.
Insider Burke Steven Keith
Role Director
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) F2 5,750 $0.00 $0.00
Grant/Award Common Stock F1 5,750 $0.00 $0.00
Holdings After Transaction: Stock Option (Right to Buy) — 5,750 contracts (Direct); Common Stock — 5,750 shares (Direct)
Footnotes (2)
  1. F1. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of common stock for each RSU upon vesting. 1/3rd of the RSUs will vest annually on the anniversary of the date of grant, with the first 1/3rd vesting on September 18, 2027, provided that the Reporting Person is providing continuous services on the applicable vesting date.
  2. F2. One third of the shares subject to this option vest on the one year anniversary of the grant date, and 1/36 of the shares subject to the option vest on each of the next 24 months thereafter provided that the Reporting Person is providing continuous services on the applicable vesting date.
Restricted stock units granted 5,750 units RSUs granted to the director on September 18, 2026
Stock options granted 5,750 options Options granted to the director on September 18, 2026
Option exercise price $4.46 per share Exercise price for the 5,750 stock options
Option expiration date September 18, 2036 Expiration of the stock options granted
First RSU vesting date September 18, 2027 First one-third of RSUs vest on this date
Common shares held after award 5,750 shares Director’s direct common stock holdings following the RSU grant
Stock options held after award 5,750 options Director’s option holdings following the new grant
restricted stock units ("RSUs") financial
"Represents restricted stock units ("RSUs") for which the Reporting Person is"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
vesting financial
"receive one (1) share of common stock for each RSU upon vesting"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
continuous services financial
"provided that the Reporting Person is providing continuous services"
grant date financial
"One third of the shares subject to this option vest on the one year anniversary of the grant date"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What new equity awards did SCYX director Steven Keith Burke receive?

He received 5,750 restricted stock units and 5,750 stock options for SCYNEXIS common stock on September 18, 2026, all granted at no cash cost to him and subject to multi-year service-based vesting schedules.

What is the exercise price and term of the new SCYX stock options?

The new stock options have an exercise price of $4.46 per share and expire on September 18, 2036. One third vests after one year, with the rest vesting in equal monthly installments over the following 24 months, subject to continued service.

How do the SCYX restricted stock units granted to the director vest?

The 5,750 restricted stock units vest in three equal annual installments. One third vests on September 18, 2027, and the remaining two thirds vest on the next two anniversaries, provided he continues to provide services on each vesting date.

How many SCYX common shares does the director hold after these awards?

After these awards, he directly holds 5,750 shares of SCYNEXIS common stock, corresponding to the newly granted restricted stock units reported as common stock, plus 5,750 stock options that are exercisable as they vest over time.

Were the SCYX director’s transactions made under a Rule 10b5-1 trading plan?

No. The disclosure indicates no Rule 10b5-1 trading plan applies to these transactions. They are equity compensation grants rather than open-market purchases or sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Burke Steven Keith

(Last)(First)(Middle)
1 EVERTRUST PLAZA
13TH FLOOR

(Street)
JERSEY CITY NEW JERSEY 07302

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
SCYNEXIS INC [ SCYX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/18/2026A5,750(1)A$0.005,750D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$4.4609/18/2026A5,750 (2)09/18/2036Common Stock5,750$0.005,750D
Explanation of Responses:
1. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of common stock for each RSU upon vesting. 1/3rd of the RSUs will vest annually on the anniversary of the date of grant, with the first 1/3rd vesting on September 18, 2027, provided that the Reporting Person is providing continuous services on the applicable vesting date.
2. One third of the shares subject to this option vest on the one year anniversary of the grant date, and 1/36 of the shares subject to the option vest on each of the next 24 months thereafter provided that the Reporting Person is providing continuous services on the applicable vesting date.
/s/ Robert F. Joyce Jr., by Power of Attorney09/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading